Company Monitoring Page for Orexigen

latest headlines for company on cafepharma

Vivus's Obesity Drug Awaiting FDA Review: Expecting Positive Ruling
Seeking Alpha
Wed, 07/14/10 - 10:35 am
Tags:
obesity, Qnexa, FDA, Vivus, Contrave, Orexigen, Arena Pharmaceuticals
Shares of obesity drugmakers rise ahead of panel
Yahoo/AP
Tue, 07/13/10 - 11:14 am
Tags:
obsesity, diet drugs, advisory panels, FDA, Qnexa, Vivus, Arena Pharmaceuticals, Contrave, Orexigen
Vivus Weight-Loss Pill Works - FDA
TheStreet.com
Tue, 07/13/10 - 08:43 am
Tags:
FDA, diet drugs, obesity, Vivus, advisory panels, Qnexa, Arena Pharmaceuticals, Orexigen, Contrave
Why the FDA Will Likely Reject 3 New Weight Loss Drugs
BNET Pharma
Mon, 07/12/10 - 02:39 pm
Tags:
FDA, Vivus, obesity, Qnexa, Orexigen, Arena Pharmaceuticals, Contrave
Biotech Stock Mailbag: Somaxon
TheStreet.com
Fri, 07/9/10 - 12:27 pm
Tags:
Somaxon, Dendreon, Arena Pharmaceuticals, Orexigen, Vivus, Roche, GSK, Immunogen
How to Trade on an FDA Advisory Panel
Minyanville
Fri, 07/9/10 - 11:38 am
Tags:
FDA, advisory panels, Qnexa, Arena Pharmaceuticals, Vivus, Orexigen
Arena, Orexigen Race for a Fat Opportunity
Seeking Alpha
Tue, 07/6/10 - 10:43 am
Tags:
obesity, Arena Pharmaceuticals, Orexigen, Contrave, Eisai
Will Prescription Diet Pills Become Hot - Again?
Pharmalot
Thu, 07/1/10 - 05:23 pm
Tags:
diet drugs, obesity, Arena Pharmaceuticals, Eisai, Contrave, Orexigen
Diabetes Drug Development Pops and Drops
Motley Fool
Wed, 06/30/10 - 09:57 am
Tags:
diabetes, Orexigen, Contrave, Avandia, GSK, Merck, Eli Lilly, Amylin, Novo Nordisk, JNJ, MannKind, Afrezza
Orexigen says obesity drug treated depression
Yahoo/AP
Mon, 06/28/10 - 02:55 pm
Tags:
Orexigen, obesity, depression, Contrave
Mark Your Calendars: Obesity Drugs Take Center Stage
Motley Fool
Sat, 06/26/10 - 09:17 am
Tags:
obesity, Orexigen, Qnexa, Vivus, Abbott Laboratories, GSK, Meridia, Alli
Orexigen says FDA sets Jan. 31 date for Contrave
Yahoo/AP
Thu, 06/17/10 - 11:03 pm
Tags:
FDA, Contrave, Orexigen, obesity
What Investors Think About Orexigen Therapeutics
Motley Fool
Wed, 06/9/10 - 08:15 am
Tags:
investors, Orexigen
Orexigen revises obesity drug data; shares fall
Reuters
Wed, 04/14/10 - 10:44 am
Tags:
obesity, Orexigen, Contrave
Xoma rallies on patents; Orexigen slides
Marketwatch
Tue, 04/13/10 - 10:46 am
Tags:
Xoma, Orexigen, patents, Contrave
New Obesity Pills: The Pipeline Getting Fat?
CNBC
Tue, 04/13/10 - 09:42 am
Tags:
obesity, Vivus, Qnexa, Arena Pharmaceuticals, Orexigen, Contrave
Orexigen asks FDA for weight-loss drug approval
Yahoo/AP
Wed, 03/31/10 - 09:51 pm
Tags:
Orexigen, FDA, obesity, Contrave, Vivus, Arena Pharmaceuticals, Qnexa
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Mon, 03/29/10 - 11:23 am
Tags:
FDA, obesity, Vivus, Orexigen, Arena Pharmaceuticals, Qnexa, Amylin
3 Ways to Play the Obesity Drugs
TheStreet.com
Tue, 03/16/10 - 10:05 am
Tags:
obesity, Arena Pharmaceuticals, Vivus, Orexigen, Contrave, Qnexa, lorcaserin
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 10:58 am
Tags:
FDA, Cadence Pharmaceuticals, Acorda Therapeutics, Auxilium, Gilead Sciences, Shire, Amylin, Cell Therapeutics, Dendreon, InterMune, Amgen, Human Genome, NicOx, Vivus, Arena Pharmaceuticals, Orexigen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.